ArticleObesity surgery2025
Weight Loss Maintenance 1 Year after the Swallowable Gastric Balloon: Results from an International Multicenter Study.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Early Termination of a First-in-Human Trial of a Swallowable Self-Expanding Intragastric Balloon (IGBalloon©) Due to Small Bowel Obstruction.Obesity surgery · 2026Trial
- Article
- Laparoscopic removal of swallowable intragastric balloon and conversion to Roux-en-Y gastric bypass with concurrent hiatoplasty: a case report.Journal of surgical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Allurion Swallowable Gastric Balloon Program (SGBP) is a non-endoscopic balloon and behavior change program for weight loss that provides remote patient monitoring, secure messaging, and telehealth via a Bluetooth-connected scale and mobile app. This study aimed to evaluate the effectiveness of the SGBP 1 year after the gastric balloon naturally exits the body, which typically happens around 4 months after balloon placement.
methodsPatients (≥ 16 years) were followed every 2 weeks during balloon residency and then monthly for 1 year after balloon passage. Weight loss (WL), total body weight loss (%TBWL), and body mass index loss (BMIL) were retrospectively analyzed from nine international obesity centers.
resultsFollow-up data were available for 522 patients (331 females, 191 males), from a database of 3716 patients, mean age 43.5 years. Mean ± SD weight and BMI before the procedure were 101.9 ± 21.2 kg and 35.9 ± 5.8 kg/m
conclusionsThe SGBP demonstrated significant four-month weight loss and weight loss maintenance 1 year after balloon passage. Close communication using a Bluetooth-connected scale and mobile app allowed for virtual follow-up during treatment and after balloon passage, and also provides a platform for follow-up after other treatments, such as surgical and medical weight loss interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.